PubRank

Gerhard Opelz

Author PubWeight™ 146.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 2007 5.31
2 Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 2002 3.75
3 Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes research. Transplantation 2008 3.43
4 Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation 2013 2.55
5 C3 polymorphisms and allograft outcome in renal transplantation. N Engl J Med 2009 2.29
6 Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees? Nat Rev Cancer 2009 2.26
7 Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantation. Transplantation 2004 2.13
8 IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism. Cancer Immunol Immunother 2008 1.88
9 H-Y as a minor histocompatibility antigen in kidney transplantation: a retrospective cohort study. Lancet 2008 1.85
10 Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO? Blood 2004 1.83
11 Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am J Transplant 2003 1.76
12 The effect of donor gender on graft survival. J Am Soc Nephrol 2002 1.72
13 No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: a Collaborative Transplant Study report. Transplantation 2011 1.67
14 Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells. Biochem Biophys Res Commun 2009 1.65
15 Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem Biophys Res Commun 2010 1.62
16 Dysregulated cytokine responses during cytomegalovirus infection in renal transplant recipients. Transplantation 2008 1.55
17 Living kidney donor follow-up: state-of-the-art and future directions, conference summary and recommendations. Am J Transplant 2011 1.51
18 Malignancy in renal transplantation. J Am Soc Nephrol 2004 1.50
19 Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells. Blood 2007 1.48
20 Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy. Transpl Int 2012 1.47
21 Urinary proinflammatory cytokine response in renal transplant recipients with polyomavirus BK viruria. Transplantation 2009 1.47
22 Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo. Transpl Int 2005 1.43
23 Ex vivo perfusion with mitomycin C containing solution prolongs heart graft survival in rats. Transplantation 2006 1.41
24 Kidney graft survival in Europe and the United States: strikingly different long-term outcomes. Transplantation 2013 1.36
25 A cell line model for the differentiation of human dendritic cells. Biochem Biophys Res Commun 2005 1.28
26 Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation. Blood 2004 1.26
27 Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells. J Cell Biochem 2008 1.20
28 Proteasome inhibition suppresses essential immune functions of human CD4+ T cells. Immunology 2008 1.14
29 The Risk of Transplant Failure With HLA Mismatch in First Adult Kidney Allografts From Deceased Donors. Transplantation 2016 1.13
30 Cytokine expression during early and late phase of acute Puumala hantavirus infection. BMC Immunol 2011 1.09
31 The immunoregulatory role of IDO-producing human dendritic cells revisited. Trends Immunol 2006 1.07
32 Kidney graft failure and presensitization against HLA class I and class II antigens. Transplantation 2002 1.04
33 Metabolic control improves long-term renal allograft and patient survival in type 1 diabetes. J Am Soc Nephrol 2008 1.02
34 Active-specific immunotherapy of human cancers with the heat shock protein Gp96-revisited. Int J Cancer 2012 1.00
35 Effect on kidney graft survival of reducing or discontinuing maintenance immunosuppression after the first year posttransplant. Transplantation 2008 1.00
36 Inosine monophosphate dehydrogenase polymorphisms and renal allograft outcome. Transplantation 2012 0.99
37 Donor ABCB1 variant associates with increased risk for kidney allograft failure. J Am Soc Nephrol 2012 0.98
38 Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival. Hum Immunol 2010 0.97
39 Salinomycin in cancer: A new mission for an old agent. Mol Med Rep 2011 0.97
40 Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients. Transplantation 2008 0.97
41 Associations of dichlorodiphenyltrichloroethane (DDT) 4.4 and dichlorodiphenyldichloroethylene (DDE) 4.4 blood levels with plasma IL-4. Arch Environ Health 2003 0.93
42 CD4+CD25+Foxp3+IFN-γ+ human induced T regulatory cells are induced by interferon-γ and suppress alloresponses nonspecifically. Hum Immunol 2011 0.93
43 Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report. Hum Immunol 2009 0.93
44 IVIG and rituximab for treatment of chronic antibody-mediated rejection: a prospective study in paediatric renal transplantation with a 2-year follow-up. Transpl Int 2012 0.93
45 Antithymocyte globulins suppress dendritic cell function by multiple mechanisms. Transplantation 2007 0.92
46 HLA antibodies and the occurrence of early adverse events in the modern era of transplantation: a collaborative transplant study report. Transplantation 2009 0.91
47 Observational support for an immunoregulatory role of CD3+CD4+CD25+IFN-gamma+ blood lymphocytes in kidney transplant recipients with good long-term graft outcome. Transpl Int 2008 0.90
48 ABO-incompatible kidney transplantation enabled by non-antigen-specific immunoadsorption. Transplantation 2012 0.89
49 HLA matching and kidney transplantation: beyond graft survival. Clin Transpl 2013 0.88
50 Current role of human leukocyte antigen matching in kidney transplantation. Curr Opin Organ Transplant 2013 0.88
51 A new epitope-based HLA-DPB matching approach for cadaver kidney retransplants. Transplantation 2003 0.88
52 An integrative approach for the transplantation of high-risk sensitized patients. Transplantation 2010 0.88
53 Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells. Immunology 2006 0.87
54 Interferon-gamma producing regulatory T cells as a diagnostic and therapeutic tool in organ transplantation. Int Rev Immunol 2013 0.86
55 Evaluation of T-cell receptor repertoires in patients with long-term renal allograft survival. Am J Transplant 2005 0.86
56 CD4+ CD25+ Foxp3+ IFNγ+ CD178+ human induced Treg (iTreg) contribute to suppression of alloresponses by apoptosis of responder cells. Hum Immunol 2012 0.86
57 Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma. Blood 2002 0.86
58 Strong inflammatory cytokine response in male and strong anti-inflammatory response in female kidney transplant recipients with urinary tract infection. Transpl Int 2005 0.86
59 Sequential analysis by immunoprecipitation-MALDI-TOF: a novel method for detection and identification of alloantibody specificities. Hum Immunol 2010 0.85
60 Apoptosis-mediated selective killing of malignant cells by cardiac steroids: maintenance of cytotoxicity and loss of cardiac activity of chemically modified derivatives. Int Immunopharmacol 2003 0.84
61 Risks of allogeneic hand transplantation. Microsurgery 2004 0.84
62 Release of soluble CD30 after allogeneic stimulation is mediated by memory T cells and regulated by IFN-γ and IL-2. Transplantation 2013 0.84
63 Generation of tolerogenic dendritic cells by treatment with mitomycin C: inhibition of allogeneic T-cell response is mediated by downregulation of ICAM-1, CD80, and CD86. Transplantation 2004 0.84
64 HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway. Biochem Biophys Res Commun 2008 0.84
65 A simplified technique for heart transplantation in rats: abdominal vessel branch-sparing and modified venotomy. Microsurgery 2006 0.83
66 CD4(+)CD25(+)Foxp3(+)IFNγ(+) Treg are immunosuppressive in vitro and increase with intensity of the alloresponse in pretransplant MLC. Transpl Immunol 2012 0.83
67 Immunosuppressive anti-immunoglobulin autoantibodies: specificity, gene structure and function in health and disease. Cell Mol Biol (Noisy-le-grand) 2002 0.83
68 Role and Value of Luminex(®)-Detected HLA Antibodies before and after Kidney Transplantation. Transfus Med Hemother 2013 0.83
69 Increased pretransplantation plasma kynurenine levels do not protect from but predict acute kidney allograft rejection. Hum Immunol 2010 0.83
70 The effect of ATG on cytokine and cytotoxic T-lymphocyte gene expression in renal allograft recipients during the early post-transplant period. Clin Transplant 2003 0.83
71 Decreasing plasma soluble IL-1 receptor antagonist and increasing monocyte activation early post-transplant may be involved in pathogenesis of delayed graft function in renal transplant recipients. Clin Transplant 2009 0.83
72 Impact of HLA matching and HLA antibodies in organ transplantation: a collaborative transplant study view. Methods Mol Biol 2012 0.83
73 Short communication: decreasing soluble CD30 and increasing IFN-gamma plasma levels are indicators of effective highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2007 0.82
74 Posttransplant sCD30 as a biomarker to predict kidney graft outcome. Clin Chim Acta 2011 0.82
75 Suppressive dendritic cells as a tool for controlling allograft rejection in organ transplantation: promises and difficulties. Hum Immunol 2008 0.82
76 Impact of maintenance immunosuppressive regimens--balance between graft protective suppression of immune functions and a near physiological immune response. Transpl Int 2011 0.82
77 Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing. Transplantation 2015 0.82
78 Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific Immunoadsorption. Transplantation 2015 0.82
79 Transplantation of the type 1 diabetic patient: the long-term benefit of a functioning pancreas allograft. Clin J Am Soc Nephrol 2010 0.81
80 In-vitro inhibition of IFNγ+ iTreg mediated by monoclonal antibodies against cell surface determinants essential for iTreg function. BMC Immunol 2012 0.81
81 Can intravenous immunoglobulin and simvastatin solve the problem of sensitization in renal transplant candidates? Int Urol Nephrol 2007 0.81
82 Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis. Atheroscler Suppl 2013 0.81
83 Analysis of KIR ligand incompatibility in human renal transplantation. Transplantation 2005 0.81
84 Expression of regulatory T-cell-related molecule genes and clinical outcome in kidney transplant recipients. Transplantation 2009 0.81
85 Association of circulating interleukin (IL)-12- and IL-10-producing dendritic cells with time posttransplant, dose of immunosuppression, and plasma cytokines in renal-transplant recipients. Transplantation 2005 0.81
86 Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30. J Am Soc Nephrol 2002 0.81
87 Cell cycle- and activation-dependent regulation of cyclosporin A-induced T cell apoptosis. Biochem Biophys Res Commun 2003 0.81
88 Helenalin suppresses essential immune functions of activated CD4+ T cells by multiple mechanisms. Mol Immunol 2009 0.81
89 ATG induction therapy: long-term effects on Th1 but not on Th2 responses. Transpl Int 2005 0.81
90 Effect of donor-specific transfusions on the outcome of renal allografts in the cyclosporine era. Transpl Int 2006 0.81
91 A fast and simple method for detecting and quantifying donor-derived cell-free DNA in sera of solid organ transplant recipients as a biomarker for graft function. Clin Chem Lab Med 2016 0.81
92 Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection. Transplantation 2003 0.81
93 Mitomycin C-treated dendritic cells inactivate autoreactive T cells: toward the development of a tolerogenic vaccine in autoimmune diseases. Proc Natl Acad Sci U S A 2008 0.81
94 Serial peripheral blood interleukin-18 and perforin gene expression measurements for prediction of acute kidney graft rejection. Transplantation 2004 0.80
95 Inhibition of heart allograft rejection with mitomycin C-treated donor dendritic cells. Transplantation 2007 0.80
96 Evidence for IFN-gamma up- and IL-4 downregulation late post-transplant in patients with good kidney graft outcome. Clin Transplant 2007 0.80
97 VEGF 936 C/T gene polymorphism in renal transplant recipients: association of the T allele with good graft outcome. Hum Immunol 2007 0.80
98 Strong association of phenylalanine and tryptophan metabolites with activated cytomegalovirus infection in kidney transplant recipients. Hum Immunol 2011 0.80
99 Mycophenolate mofetil-based immunosuppression and cytokine genotypes: effects on monokine secretion and antigen presentation in long-term renal transplant recipients. Transplantation 2003 0.79
100 Does growth hormone treatment affect the risk of post-transplant renal cancer? Pediatr Nephrol 2002 0.79
101 Posttransplant sCD30 as a predictor of kidney graft outcome. Transplantation 2011 0.79
102 Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I. Hum Immunol 2004 0.79
103 Proteasome inhibition activates the mitochondrial pathway of apoptosis in human CD4+ T cells. J Cell Biochem 2009 0.79
104 Association of high pretransplant sIL-6R plasma levels with acute tubular necrosis in kidney graft recipients. Transplantation 2006 0.79
105 Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma. Blood 2010 0.79
106 Soluble CD30 and ELISA-detected human leukocyte antigen antibodies for the prediction of acute rejection in pediatric renal transplant recipients. Transpl Int 2012 0.79
107 Evaluation of hepatocyte growth factor as a sensitive marker for early detection of acute renal allograft rejection. Transplantation 2007 0.79
108 Soluble CD30 as a predictor of kidney graft outcome. Transplantation 2002 0.79
109 Birth order and outcome after HLA-identical sibling donor transplantation. Blood 2009 0.79
110 Strong human leukocyte antigen matching effect in nonsensitized kidney recipients with high pretransplant soluble CD30. Transplantation 2003 0.78
111 Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedication. Transplantation 2008 0.78
112 Immunosuppressive effect of tryptophan metabolites in composite tissue allotransplantation. Plast Reconstr Surg 2007 0.78
113 Plasmapheresis adjusts inflammatory responses in potential kidney transplant recipients. Transplantation 2013 0.78
114 Relevance of IL10, TGFbeta1, TNFalpha, and IL4Ralpha gene polymorphisms in kidney transplantation: a collaborative transplant study report. Am J Transplant 2004 0.78
115 Pathway of apoptosis induced in Jurkat T lymphoblasts by anti-HLA class I antibodies. Hum Immunol 2004 0.78
116 Alloantigen-stimulated induction and release of CD30 in patients with end-stage renal failure. Hum Immunol 2012 0.78
117 Normal or even increased dendritic cell and peripheral blood lymphocyte subsets with regulatory phenotype in clinically stable long-term HIV-infected patients with hemophilia on highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2008 0.77
118 Deleterious impact of mismatching for human leukocyte antigen-C in presensitized recipients of kidney transplants. Transplantation 2011 0.77
119 Deleterious impact of HLA-DRB1 allele mismatch in sensitized recipients of kidney retransplants. Transplantation 2013 0.77
120 Prevention of antibody-mediated kidney transplant rejection. Transpl Int 2012 0.77
121 Increased serum levels of quinolinic acid indicate enhanced severity of hepatic dysfunction in patients with liver cirrhosis. Hum Immunol 2012 0.77
122 Transmission of donor-derived small-cell carcinoma cells by a nontumor-bearing allograft. Transplantation 2005 0.77
123 Association of high IFN-gamma plasma levels with low B-cell counts in renal transplant recipients with stable long-term graft function. Clin Transplant 2009 0.77
124 President's Address. The Transplantation Society--Berlin 2012. Transplantation 2013 0.77
125 Immunological relevance of CREG matching in cadaver kidney transplantation. Transplantation 2004 0.77
126 Single-chain Fv-based affinity purification of the cellular stress protein gp96 for vaccine development. Methods Mol Biol 2003 0.77
127 Role of human corneal endothelial cells in T-cell-mediated alloimmune attack in vitro. Invest Ophthalmol Vis Sci 2014 0.76
128 Does borderline kidney allograft rejection always require treatment? Transplantation 2010 0.76
129 Association of IL-12+ DC with High CD3+CD4-DR+ lymphocyte counts in long-term HIV-infected hemophilia patients with clinically stable disease. J Clin Immunol 2007 0.76
130 HLA antibody screening in kidney transplantation: current guidelines. Langenbecks Arch Surg 2013 0.76
131 Increased peripheral blood leukocyte subsets with regulatory phenotype in clinically stable long-term HIV-infected hemophilia patients on HAART may be beneficial and contribute to a decrease in autoimmunity. Viral Immunol 2010 0.76
132 The role of pretransplant dialysis modality on renal allograft outcome. Nephrol Dial Transplant 2011 0.76
133 Induction of apoptosis in human lymphocytes by human anti-HLA class I antibodies. Transplantation 2003 0.76
134 Outcomes of kidney transplant tourism in children: a single center experience. Pediatr Nephrol 2009 0.76
135 Reduction of skeletal muscle injury in composite tissue allotransplantation by heat stress preconditioning. Plast Reconstr Surg 2004 0.76
136 High urine sIL-6R as a predictor of late graft failure in renal transplant recipients. Transplantation 2003 0.76
137 Longitudinal analysis of T-helper cell phenotypes in renal-transplant recipients undergoing growth hormone therapy. Transplantation 2004 0.76
138 The Authors' Reply. Transplantation 2016 0.75
139 Successful deceased-donor kidney transplantation in crossmatch-positive patients with peritransplant plasma exchange and Rituximab. Transplantation 2009 0.75
140 A positive crossmatch and treatment with IvIg. Am J Transplant 2005 0.75
141 Response to A reassessment of the Survival Advantage of Simultaneous Kidney-Pancreas Versus Kidney-Alone Transplantation. Transplantation 2015 0.75
142 Kidney transplantation in highly sensitized patients: are there options to overcome a positive crossmatch? Langenbecks Arch Surg 2011 0.75
143 Cell therapy for immunosuppression after kidney transplantation. Langenbecks Arch Surg 2015 0.75
144 Clinical relevance of immune monitoring in solid organ transplantation. Int Rev Immunol 2009 0.75
145 Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation. Transplantation 2017 0.75
146 No association of factor V Leiden, prothrombin G20210A, and MTHFR C677T gene polymorphisms with kidney allograft survival: a multicenter study. Transplantation 2007 0.75
147 One thousand renal transplants in Belfast (1968-1998). Clin Transpl 2004 0.75
148 Clinical outcome with low-dose valacyclovir in high-risk renal transplant recipients: a 10-year experience. Nephrol Dial Transplant 2012 0.75
149 Association of pretransplant soluble glycoprotein 130 (sgp130) plasma levels and posttransplant acute tubular necrosis in renal transplant recipients. Transplantation 2009 0.75
150 Mitomycin C-treated antigen-presenting cells as a tool for control of allograft rejection and autoimmunity: from bench to bedside. Hum Immunol 2009 0.75
151 Vitamin D and Th17 Lymphocytes. Transplantation 2017 0.75
152 From cancer to transplantation: an evaluation of period analysis for calculating up-to-date long-term survival estimates. Am J Epidemiol 2010 0.75
153 Correction: Helios expression and Foxp3 TSDR methylation of IFNy+ and IFNy- Treg from kidney transplant recipients with good long-term graft function. PLoS One 2017 0.75
154 Subjective and quantitative assessment of patient fitness for cadaveric kidney transplantation: the "equity penalty". Transplantation 2003 0.75
155 Paul Ichiro Terasaki September 10, 1929 to January 25, 2016: Transplant Pioneer. Transplantation 2016 0.75
156 Genetic polymorphisms of adhesion molecules and kidney transplant survival. Transplantation 2010 0.75
157 Management of sensitized patients awaiting renal transplantation: does sequential therapy of intravenous immunoglobulin and simvastatin offer a solution? Eur J Pharmacol 2007 0.75
158 Association of single nucleotide polymorphisms on chromosome 9p21.3 with cardiovascular death in kidney transplant recipients. Transplantation 2013 0.75
159 A new HLA-DRB allele (DRB1*15014) identified in a Caucasian individual. Hum Immunol 2003 0.75
160 Dissociation of CD4(+) cell counts from viral load and association with immune complexes in HIV(+) hemophilia patients. Immunol Lett 2004 0.75